Cole G Bradley's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Jul 31, 2026
- Accession no.
- 0001337798-26-000004
- Filed
- Jul 31, 2026, 4:34 PM ET
- Trade date
- Jul 29, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $299.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cole G BradleyCIK 0001337798 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Class A Ordinary Share | SSaleDisposed | −3,673 | $81.43 | −$299,092.39 | 11,672 | Direct | |
| Jul 29, 2026 | Class A Ordinary Share | GGiftDisposed | −4,500 | $0.00 | $0 | 7,172 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.